# Interventions Against Insulin Resistance in Pulmonary Arterial Hypertension

> **NCT03617458** · PHASE2 · COMPLETED · sponsor: **Vanderbilt University Medical Center** · enrollment: 73 (actual)

## Conditions studied

- Pulmonary Artery Hypertension

## Interventions

- **DRUG:** Metformin
- **DRUG:** Placebo
- **DEVICE:** mHealth Intervention
- **DEVICE:** Usual Care

## Key facts

- **NCT ID:** NCT03617458
- **Lead sponsor:** Vanderbilt University Medical Center
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2018-08-23
- **Primary completion:** 2023-09-09
- **Final completion:** 2025-08-19
- **Target enrollment:** 73 (ACTUAL)
- **Last updated:** 2025-09-22

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03617458

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03617458, "Interventions Against Insulin Resistance in Pulmonary Arterial Hypertension". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT03617458. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*